Various analysts regularly publish their assessments of the GF share as well as studies on how they expect the company to perform.
The table shows a selection of these analysts and their assessments – we make no claim that the list is complete or up-to-date. The evaluations, judgements and expectations do not necessarily reflect the opinion of GF or its management.
If you wish to receive a copy of a particular study, please contact the analyst.
Date |
Broker |
Analyst |
Rating |
|---|---|---|---|
| 02.05.2022 | Baader Helvea | Christian Obst | Buy |
| 27.04.2022 | Credit Suisse | Patrick Laager | Outperform |
| 01.04.2022 | Kepler Cheuvreux | Martin Flückiger | Hold |
| 23.03.2022 | Stifel | Tobias Fahrenholz | Buy |
| 11.04.2022 | Mirabaud | Daniel König | Buy |
| 01.04.2022 | Octavian | Alessandro Foletti | Hold |
| 04.04.2022 | Research Partners | Patrick Appenzeller | Buy |
| 12.04.2022 | UBS | Joern Iffert | Buy |
| 05.04.2022 | Vontobel | Bernd Pomrehn | Buy |
| 14.03.2022 | ZKB | Walter Bamert | Market Perform |
Updated: 02 May 2022
